A Proof of Concept for Biomarker-Guided Targeted Therapy against Ovarian Cancer Based on Patient-Derived Tumor Xenografts.
第一作者:
Adam C,Palmer
第一单位:
Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts.;Department of Pharmacology, Computational Medicine Program, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
作者:
医学主题词
抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);抗药性, 肿瘤(Drug Resistance, Neoplasm);女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);分子靶向治疗(Molecular Targeted Therapy);卵巢肿瘤(Ovarian Neoplasms);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1158/0008-5472.CAN-19-3850
PMID
32747364
发布时间
2021-04-02
基金项目
T32 GM007753/GM/NIGMS NIH HHS/United States
U54 CA225088/CA/NCI NIH HHS/United States
- 浏览1
Cancer research
4278-4287页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



